Anti-Trbc1 Car-T Cells

Refractory/Recurrent Peripheral T-cell Lymphoma

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityCell therapyPhase 1

—

Rating in progress

Anti-Trbc1 Car-T Cells in Refractory/Recurrent Peripheral T-cell Lymphoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active